Evidence map›Paper›PMID 16040975›Full record

ArticleInfection and immunity2005

Capsule and fimbria interaction in Klebsiella pneumoniae.

Mark A Schembri, Jens Blom, Karen A Krogfelt, Per Klemm

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 177 citations in OpenAlex.

  1. Article
  2. Article
  3. Hypermucoviscosity inJournal of bacteriology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in microbiology · 2026
    Article
  10. International journal of molecular sciences · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. mBio · 2025
    Article
  17. Antimicrobial resistance and virulence inAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Mark A SchembriSchool of Molecular and Microbial Sciences, Bldg. 76, The University of Queensland, Brisbane, Qld 4072, Australia. m.schembri@uq.edu.au
Jens Blom
Karen A Krogfelt
Per Klemm
Statens Serum Institut · DKTechnical University of Denmark · DKUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The capsular polysaccharide and type 1 fimbriae are two of the major surface-located virulence properties associated with the pathogenesis of Klebsiella pneumoniae. The capsule is an elaborate polysaccharide matrix that encases the entire cell surface and provides resistance against many host defense mechanisms. In contrast, type 1 fimbriae are thin adhesive thread-like surface organelles that can extend beyond the capsular matrix and mediate d-mannose-sensitive adhesion to host epithelial cells. These fimbriae are archetypical and consist of a major building block protein (FimA) that comprises the bulk of the organelle and a tip-located adhesin (FimH). It is assumed that the extended major-subunit protein structure permits the FimH adhesin to function independently of the presence of a capsule. In this study, we have employed a defined set of K. pneumoniae capsulated and noncapsulated strains to show that the function of type 1 fimbriae is actually impeded by the concomitant expression of a polysaccharide capsule. Capsule expression had significant effects on two parameters commonly used to define FimH function, namely, yeast cell agglutination and biofilm formation. Our data suggest that this effect is not due to transcriptional/translational changes in fimbrial gene/protein expression but rather the result of direct physical interference. This was further demonstrated by the fact that we could restore fimbrial function by inhibiting capsule synthesis. It remains to be determined whether the expression of these very different surface components occurs simply via random events of phase variation or in a coordinated manner in response to specific environmental cues.

Indexed as

Bacterial CapsulesBiofilmsFimbriae, BacterialFimbriae ProteinsKlebsiella pneumoniaeMicroscopy, ElectronPromoter Regions, GeneticFimbriae Proteinsfimbrillin

Identifiers

PMID16040975
PMCPMC1201234
OpenAlexW2128345057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.